Scientists of the Cluster of Excellence CECAD, University of Cologne, have developed a new strategy for cancer treatment.
Tumor growth is dependent on attracting blood vessels, that supply nutrients and oxygen and dispose of metabolic waste. An insufficient blood supply results in significantly reduced tumor growth.
The poisoning of the mitochondria, the cell´s power-plants, inhibits blood vessel growth, but has no effects on existing vessels. For this purpose the scientists used the weak mitochondrial poison Embelin. Selective inhibition of mitochondrial function could represent a fundamentally new therapeutic approach that may help advance the development of cancer treatments.
Cologne, 2014, March 20. A team of researchers from five CECAD departments led by PD Dr. Hamid Kashkar (University Hospital of Cologne, Institute of Clinical Microbiology, Immunology and Hygiene) and Dr. Oliver Coutelle (University Hospital of Cologne, Department of Internal Medicine I) have found a new principle for the treatment of proliferating solid tumors.
Tumors are highly dependent on the growth of blood vessels supplying nutrients and oxygen and excreting CO2 and metabolic waste products. Accordingly, the inhibition of tumor blood vessels by blocking specific vascular growth factors is a strategy that is already being used successfully to treat tumors today.
In close collaboration with Dr. Hue-Tran Hornig-Do and Prof. Dr. Rudolf Wiesner (University Hospital of Cologne, Institut of Vegetative Physiology), the CECCAD team reports in a recent article in EMBO Mol Med, that Embelin, a substance that is used in African traditional medicine, inhibits vessel growth by a novel mechanism.
They showed that Embelin acts as a weak poison for mitochondria, the power plants of cells. They demonstrated that growing blood vessels – but not resting normal blood vessels – are highly dependent on mitochondrial function and have little capacity to compensate for mitochondrial dysfunction induced by Embelin. Together their findings show that Embelin significantly slowed the growth of tumors by inhibiting their blood supply, but had little effect on existing normal blood vessels and other tissues at the concentrations required.
The study was supported by further research in collaboration with Prof. Sabine Eming (University of Cologne, Dermatology). Wound healing experiments demonstrated delayed closure of wounds in the presence of Embelin due to the lack of blood vessel in-growth, providing additional evidence for the effectiveness of Embelin in inhibiting new blood vessel formation.
Experiments in cooperation with Prof. Aleksandra Trifunovic ( CECAD) provide additional support for the dependence of new blood vessels on adequate mitochondrial function. In particular, mitochondrial dysfunction induced by mutation in mitochondrial DNA severely impaired the capacity for vascularisation of implanted artificial plugs, designed to attract new blood vessels.
In summary, the scientists were able to prove that impairment of mitochondrial function provides a fundamentally new approach to inhibit blood vessel growth in solid tumors with little side effects on normal body functions. Prof. Dr. Rudolf Wiesner: „We all feel excited about this new principle that will provide new approaches in the fight against cancer.“
Dr. Oliver Coutelle
PD Dr. Hamid Kashkar
Leiterin CECAD PR & Marketing
Tel. + 49 (0) 221-478-84043
Astrid Bergmeister | idw - Informationsdienst Wissenschaft
A New Discovery in the Fight against Cancer: Tumor Cells Switch to a Different Mode
29.04.2016 | Universität Basel
Bearded dragons show REM and slow wave sleep
29.04.2016 | Max-Planck-Institut für Hirnforschung
Researchers from the Max Planck Institute Stuttgart have developed self-propelled tiny ‘microbots’ that can remove lead or organic pollution from contaminated water.
Working with colleagues in Barcelona and Singapore, Samuel Sánchez’s group used graphene oxide to make their microscale motors, which are able to adsorb lead...
Neutron scattering and computational modeling have revealed unique and unexpected behavior of water molecules under extreme confinement that is unmatched by any known gas, liquid or solid states.
In a paper published in Physical Review Letters, researchers at the Department of Energy's Oak Ridge National Laboratory describe a new tunneling state of...
Honeycomb structures as the basic building block for industrial applications presented using holo pyramid
Researchers of the Alfred Wegener Institute (AWI) will introduce their latest developments in the field of bionic lightweight design at Hannover Messe from 25...
Polymer solar cells can be even cheaper and more reliable thanks to a breakthrough by scientists at Linköping University and the Chinese Academy of Sciences (CAS). This work is about avoiding costly and unstable fullerenes.
Polymer solar cells can be even cheaper and more reliable thanks to a breakthrough by scientists at Linköping University and the Chinese Academy of Sciences...
As one of the leading R&D partners in the development of surface technologies and organic electronics, the Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP will be exhibiting its recent achievements in vacuum coating of ultra-thin glass at SVC TechCon 2016 (Booth 846), taking place in Indianapolis / USA from May 9 – 13.
Fraunhofer FEP is an experienced partner for technological developments, known for testing the limits of new materials and for optimization of those materials...
27.04.2016 | Event News
15.04.2016 | Event News
12.04.2016 | Event News
29.04.2016 | Life Sciences
28.04.2016 | Physics and Astronomy
28.04.2016 | Materials Sciences